Drug Discovery Today: November Issue

The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.

Our November issue review highlights includes:

  • PET imaging with small-molecule TKIs 
  • Targeting mutant huntingtin: disease-modifying therapy
  •  Repurpose drugs for CNS diseases
  • Ultra-adaptable nanovesicular systems
Cover Story
The leading story of this issue of Drug Discovery Today, Paul Slobbe, Alex J. Poot, Albert D. Windhorst and Guus A.M.S. van Dongen focus on small molecule TKIs that have been approved by the US Food and Drug Administration (FDA), their relative limited efficacy in today’s cancer treatment and the role that positron emission tomography (PET) with radiolabeled TKIs (TKI-PET) can have in a personalized treatment approach and improvement of the therapeutic successes.
Click here to view the Drug Discovery Today November issue on ScienceDirect
To register for the Drug Discovery Today Digital Edition click here.

Share this article

More services


This article is featured in:
The View From Here


Comment on this article

You must be registered and logged in to leave a comment about this article.